Results 101 to 110 of about 63,478,598 (186)
Interleukin-4 (IL-4) and interleukin-10 (IL-10) are key cytokines whose increased production during systemic HIV infection has been associated with decreased cellular immunity during AIDS.
Hsin Chien +2 more
core +1 more source
BACKGROUND: Idiopathic immune thrombocytopenia purpura is an autoimmune bleeding disorder that accounts for approximately one-third of clinical hemorrhagic diseases.
Aisha Muthanna Shanshal +2 more
doaj +1 more source
Retracted: Elevated Plasma Interleukin-35 as a Prognostic Indicator in Localized Clear Cell Renal Cell Carcinoma. [PDF]
And Alternative Medicine EC.
europepmc +1 more source
Interleukin-35: A Novel Mediator of Peripheral Tolerance
Interleukin-35 is a potent suppressive cytokine of the IL-12 family. Although other members of the IL-12 family are produced mainly by antigen-presenting cells (APCs), IL-35 is produced by regulatory T (Treg) cells and suppresses cell proliferation. It has been shown to play an important role in many disease models and has been recently shown to have ...
Delgoffe, Greg M., Vignali, Dario A. A.
openaire +1 more source
Effect of T-regulatory cells and interleukin-35, interleukin-10, and transforming growth factor-beta on diffuse large B-cell lymphoma. [PDF]
Wu H, Sun HC, Ouyang GF.
europepmc +1 more source
Background: Type 2 diabetes mellitus (DM) and chronic periodontitis (CP) show common pathophysiological features. We investigated the serum levels of IL-23 and IL-35 in people with type 2 DM and CP.
Avideh Maboudi +8 more
doaj
The Framework of Host Innate and Adaptive Immunological Pathways
Background: Host immune responses can be broadly divided into innate and adaptive immunity. Numerous adaptive immune responses have been identified, including TH1, TH2, TH3, TH9, TH17, and TH22 immunity.
Wan-Chung Hu
doaj +1 more source
Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance
Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin ...
LA Zaffino (15871433) +10 more
core
Retraction: Colon cancer-induced interleukin-35 inhibits beta-catenin-mediated pro-oncogenic activity. [PDF]
Jiang Y, Ma Y, Li R, Sun J.
europepmc +1 more source

